Αποτελέσματα Αναζήτησης
1 Αυγ 2023 · Secondary Prevention. Secondary prevention emphasizes early disease detection, and its target is healthy-appearing individuals with subclinical forms of the disease. The subclinical disease consists of pathologic changes but no overt symptoms that are diagnosable in a doctor's visit. Secondary prevention often occurs in the form of screenings.
16 Δεκ 2021 · Recommendation. 3.9 In adults with overweight/obesity at high risk of type 2 diabetes, care goals should include weight loss or prevention of weight gain, minimizing progression of hyperglycemia, and attention to cardiovascular risk and associated comorbidites.
1 Οκτ 2021 · ASCVD is the leading cause of morbidity and mortality for individuals with diabetes.2 There are many cardiovascular (CV) risk factors that are targets in both the primary and secondary prevention of ASCVD. Attention should be given to key factors or conditions that, when improved or controlled, have demonstrated lower rates of ASCVD, including ...
16 Ιουν 2017 · Achievement of guideline-recommended prevention measures can reduce CVD risk in adults with diabetes mellitus and CVD, yet the degree to which these high-risk adults are achieving guideline-indicated secondary prevention interventions has been understudied globally.
4 Δεκ 2020 · Subgroup analyses of patients with diabetes in larger trials (85–89) and trials in patients with diabetes (90,91) showed significant primary and secondary prevention of ASCVD events and CHD death in patients with diabetes.
4 Μαρ 2024 · Antiplatelet agents, including monotherapies (e.g., aspirin or P2Y12 inhibitors) and dual antiplatelet therapy (DAPT) (e.g., concurrent use of aspirin and P2Y12 inhibitors), hold indispensable value as secondary preventive pharmacological agents for patients with diabetes .
5 Ιαν 2019 · These data suggest that SGLT2i should be considered in patients with type 2 diabetes regardless of presence of atherosclerotic cardiovascular disease or history of heart failure, given that SGLT2i safely reduce HbA 1c and reduce the risk of hospitalisation for heart failure and progression of renal disease across a broad spectrum of patients ...
